Dare Bioscience, Inc. (DARE) Operating income 2016–2025
Dare Bioscience, Inc. (DARE) annual operating income history from SEC filings — each fiscal year as reported.
-$13.6MFY2025 · since FY2016: -$630,591 → -$13.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.6M | +42.2% |
| FY2024 | -$23.5M | +24.2% |
| FY2023 | -$30.9M | +1.4% |
| FY2022 | -$31.4M | +19.7% |
| FY2021 | -$39.1M | -42.6% |
| FY2020 | -$27.4M | -91.0% |
| FY2019 | -$14.3M | +15.0% |
| FY2018 | -$16.9M | -51.0% |
| FY2017 | -$11.2M | -1673.0% |
| FY2016 | -$630,591 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DARE financial trends
DARE RevenueDARE Net incomeDARE Net marginDARE Gross profitDARE Gross marginDARE Operating marginDARE Operating cash flowDARE Free cash flowDARE Capital expendituresDARE Return on equityDARE Stock buybacksDARE Dividends paidDARE Total assetsDARE Total liabilitiesDARE Shareholders’ equityDARE overview →